23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Boston Scientific Corporation › 2025-2026

Boston Scientific Corporation 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Boston Scientific Corporation’s Form 8-K, filed May 5, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 17Ballot items
  • 1,259Asset managers, any item
  • 21,280Fund votes
  • April 30, 2026Meeting date

Results at a glance

Meeting of April 30, 2026: 17 items on Boston Scientific Corporation’s Form 8-K, filed May 5, 2026: 10 elected · 5 approved · 2 not approved.

Not approved or not elected

Dissent

High dissent: 1 shareholder proposal (42.8% support).

Notable dissent: 1 director (14.1% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Boston Scientific Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Boston Scientific Corporation

These tallies are Boston Scientific Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Boston Scientific Corporation — official shareholder meeting results, meeting held April 30, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: David C. Habiger 1,037,805,652169,730,1062,858,635 --81,271,529 86%Elected—
Elect Director: Edward J. Ludwig 1,156,469,56050,835,6363,089,197 --81,271,529 96%Elected—
Elect Director: Michael F. Mahoney 1,113,612,01693,613,0273,169,350 --81,271,529 92%Elected—
Elect Director: Jessica L. Mega 1,196,020,67611,532,0452,841,672 --81,271,529 99.0%Elected—
Elect Director: Susan E. Morano 1,171,890,41735,662,9321,841,044 --81,271,529 97%Elected—
Elect Director: Cheryl Pegus 1,195,889,56211,653,8322,850,999 --81,271,529 99.0%Elected—
Elect Director: Cathy R. Smith 1,117,908,89688,044,9114,440,586 --81,271,529 93%Elected—
Elect Director: Christophe P. Weber 1,205,365,6372,260,2562,768,500 --81,271,529 99.8%Elected—
Elect Director: David S. Wichmann 1,198,736,1858,393,0383,265,170 --81,271,529 99.3%Elected—
Elect Director: Ellen M. Zane 1,150,092,66856,753,5533,548,172 --81,271,529 95%Elected—
2. The compensation of the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the Annual Meeting 1,096,889,576110,645,8132,859,004 --81,271,529 91%Approved—
3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal year 1,169,955,769116,874,2434,835,910 --0 91%Approved—
4. The amendment of the Company's Employee Stock Purchase Plan to increase the number of shares reserved for issuance 1,205,130,0322,818,6672,445,694 --81,271,529 99.8%Approved—
5. The amendment of the Company's Third Restated Certificate of Incorporation to remove supermajority voting provisions 1,189,271,43117,774,0533,348,909 --81,271,529 99%Approved—
6. The amendment of the Company's Third Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law 1,057,086,923150,458,6332,848,837 --81,271,529 88%Approved—
7. The amendment of the Company's Third Restated Certificate of Incorporation and Amended and Restated By-Laws to permit stockholders owning not less than 25% of the Company's common stock to call a special meeting of stockholders 1,095,371,43020,945,18394,077,780 --81,271,529 98%Not approved
Not approved: the filing states that this item needed more than a majority of the votes cast.
—
8. Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." 516,140,863689,739,6054,513,925 --81,271,529 43%Not approved—

Source: Boston Scientific Corporation, Form 8-K, filed with the SEC on May 5, 2026 — read the filing on EDGAR.

How asset managers voted at the Boston Scientific Corporation 2025-2026 meeting

1,259 asset managers disclosed a vote on at least one Boston Scientific Corporation item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: David C. Habiger

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%AGAINST
FOR: 1,037,805,652AGAINST: 169,730,106

Prior year: 95.3% for (May 1, 2025 meeting) ▼ 9.4 pts

Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: Proposal to elect ten Directors: David C. Habiger

Boston Scientific Corporation’s own tally for this item (“Elect Director: David C. Habiger”): 1,037,805,652 for, 169,730,106 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 445,056,498 for, 32,670,409 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 445,056,498AGAINST: 32,670,409ABSTAIN: 142,670UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “Proposal to elect ten Directors: David C. Habiger” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard155,269,86010,730,048 150Mixed
Fidelity97,156,09220,264 00For
BlackRock47,761,3770 00For
State Street18,264,3400 00For
Capital Group016,587,637 00Against
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND02,393,727 00Against
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,542,41322,548 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

Elect Director: Edward J. Ludwig

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 1,156,469,560AGAINST: 50,835,636

Prior year: 96.7% for (May 1, 2025 meeting) ▼ 0.9 pts

Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: Proposal to elect ten Directors: Edward J. Ludwig

Boston Scientific Corporation’s own tally for this item (“Elect Director: Edward J. Ludwig”): 1,156,469,560 for, 50,835,636 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 477,276,087 for, 450,820 against, 142,672 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 477,276,087AGAINST: 450,820ABSTAIN: 142,672UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “Proposal to elect ten Directors: Edward J. Ludwig” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,999,660248 170For
Fidelity97,176,3560 00For
BlackRock47,761,3770 00For
State Street18,264,131209 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,564,9610 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

Elect Director: Michael F. Mahoney

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 1,113,612,016AGAINST: 93,613,027

Prior year: 92.8% for (May 1, 2025 meeting) ▼ 0.5 pts

Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: Proposal to elect ten Directors: Michael F. Mahoney

Boston Scientific Corporation’s own tally for this item (“Elect Director: Michael F. Mahoney”): 1,113,612,016 for, 93,613,027 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 477,695,132 for, 31,777 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 477,695,132AGAINST: 31,777ABSTAIN: 142,670UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “Proposal to elect ten Directors: Michael F. Mahoney” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,999,408502 150For
Fidelity97,176,3560 00For
BlackRock47,761,3770 00For
State Street18,264,224116 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,542,41322,548 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

Elect Director: Jessica L. Mega

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 1,196,020,676AGAINST: 11,532,045

Prior year: 99.5% for (May 1, 2025 meeting) ▼ 0.5 pts

Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: Proposal to elect ten Directors: Jessica L. Mega

Boston Scientific Corporation’s own tally for this item (“Elect Director: Jessica L. Mega”): 1,196,020,676 for, 11,532,045 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 477,594,300 for, 132,605 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 477,594,300AGAINST: 132,605ABSTAIN: 142,670UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “Proposal to elect ten Directors: Jessica L. Mega” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,999,87729 150For
Fidelity97,176,3560 00For
BlackRock47,761,3770 00For
State Street18,264,3400 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,564,9610 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

Elect Director: Susan E. Morano

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 1,171,890,417AGAINST: 35,662,932

Prior year: 99.8% for (May 1, 2025 meeting) ▼ 2.8 pts

Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: Proposal to elect ten Directors: Susan E. Morano

Boston Scientific Corporation’s own tally for this item (“Elect Director: Susan E. Morano”): 1,171,890,417 for, 35,662,932 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 477,092,478 for, 634,431 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 477,092,478AGAINST: 634,431ABSTAIN: 142,670UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “Proposal to elect ten Directors: Susan E. Morano” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,883,457116,455 150For
Fidelity97,176,3560 00For
BlackRock47,752,8488,529 00For
State Street18,264,3400 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,564,9610 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

Elect Director: Cheryl Pegus

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 1,195,889,562AGAINST: 11,653,832

Prior year: 99.8% for (May 1, 2025 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: Proposal to elect ten Directors: Cheryl Pegus

Boston Scientific Corporation’s own tally for this item (“Elect Director: Cheryl Pegus”): 1,195,889,562 for, 11,653,832 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 477,594,300 for, 132,606 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 477,594,300AGAINST: 132,606ABSTAIN: 142,670UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “Proposal to elect ten Directors: Cheryl Pegus” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,999,87730 150For
Fidelity97,176,3560 00For
BlackRock47,761,3770 00For
State Street18,264,3400 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,564,9610 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

Elect Director: Cathy R. Smith

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 1,117,908,896AGAINST: 88,044,911
Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: Proposal to elect ten Directors: Cathy R. Smith

Boston Scientific Corporation’s own tally for this item (“Elect Director: Cathy R. Smith”): 1,117,908,896 for, 88,044,911 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 459,103,552 for, 18,623,346 against, 142,680 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 459,103,552AGAINST: 18,623,346ABSTAIN: 142,680UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “Proposal to elect ten Directors: Cathy R. Smith” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,883,103116,798 250For
Fidelity97,176,3560 00For
BlackRock47,745,01716,360 00For
State Street18,264,3400 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab7,1938,681,824 00Against
Parnassus07,000,646 00Against
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,542,41322,548 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

Elect Director: Christophe P. Weber

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 1,205,365,637AGAINST: 2,260,256
Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: Proposal to elect ten Directors: Christophe P. Weber

Boston Scientific Corporation’s own tally for this item (“Elect Director: Christophe P. Weber”): 1,205,365,637 for, 2,260,256 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 477,701,900 for, 25,009 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 477,701,900AGAINST: 25,009ABSTAIN: 142,670UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “Proposal to elect ten Directors: Christophe P. Weber” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,999,9019 150For
Fidelity97,176,3560 00For
BlackRock47,761,3770 00For
State Street18,264,3400 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,564,9610 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

Elect Director: David S. Wichmann

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 1,198,736,185AGAINST: 8,393,038

Prior year: 99.1% for (May 1, 2025 meeting) ▲ 0.2 pts

Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: Proposal to elect ten Directors: David S. Wichmann

Boston Scientific Corporation’s own tally for this item (“Elect Director: David S. Wichmann”): 1,198,736,185 for, 8,393,038 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 477,636,681 for, 90,226 against, 142,670 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 477,636,681AGAINST: 90,226ABSTAIN: 142,670UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “Proposal to elect ten Directors: David S. Wichmann” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,999,87038 150For
Fidelity97,176,3560 00For
BlackRock47,761,3770 00For
State Street18,264,3400 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,564,9610 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

Elect Director: Ellen M. Zane

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 1,150,092,668AGAINST: 56,753,553

Prior year: 97.0% for (May 1, 2025 meeting) ▼ 1.7 pts

Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: Proposal to elect ten Directors: Ellen M. Zane

Boston Scientific Corporation’s own tally for this item (“Elect Director: Ellen M. Zane”): 1,150,092,668 for, 56,753,553 against, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company's 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 477,278,422 for, 448,480 against, 142,673 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 477,278,422AGAINST: 448,480ABSTAIN: 142,673UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “Proposal to elect ten Directors: Ellen M. Zane” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,999,636267 180For
Fidelity97,176,3560 00For
BlackRock47,761,3770 00For
State Street18,264,3400 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,564,9610 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

The amendment of the Company's Third Restated Certificate of Incorporation to provide for exculpation of certain…

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

88% Approved · of votes cast

FOR 88%
FOR: 1,057,086,923AGAINST: 150,458,633
Details: description as filed, official tally, votes by 210 asset managers

Description as filed by funds: To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.

Boston Scientific Corporation’s own tally for this item (“6. The amendment of the Company's Third Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law”): 1,057,086,923 for, 150,458,633 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(6) The stockholders approved the amendment of the Company's Third Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 210 asset managers below reported 455,750,059 for, 21,951,848 against, 167,670 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 455,750,059AGAINST: 21,951,848ABSTAIN: 167,670UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaw” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,882,802117,107 150For
Fidelity97,176,3560 00For
BlackRock47,720,15441,223 00For
State Street18,262,6011,739 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan08,850,564 00Against
Charles Schwab8,686,4952,522 00For
Parnassus07,000,646 00Against
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,491,857196,423 00Mixed
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman01,605,985 00Against
Equitable1,564,9610 00For

Showing the 25 largest of 210 asset managers. All 210 are in the interactive database (link above).

The amendment of the Company's Third Restated Certificate of Incorporation to remove supermajority voting provisions

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 1,189,271,431AGAINST: 17,774,053
Details: description as filed, official tally, votes by 204 asset managers

Description as filed by funds: To amend our Certificate of Incorporation to remove supermajority voting provisions.

Boston Scientific Corporation’s own tally for this item (“5. The amendment of the Company's Third Restated Certificate of Incorporation to remove supermajority voting provisions”): 1,189,271,431 for, 17,774,053 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(5) The stockholders approved the amendment of the Company's Third Restated Certificate of Incorporation to remove supermajority voting provisions.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 204 asset managers below reported 476,479,462 for, 50,103 against, 18 abstained, 1,125 not voted, 24,011 unknown.

FOR
FOR: 476,479,462AGAINST: 50,103ABSTAIN: 18UNKNOWN: 24,011NOT VOTED: 1,125
Largest asset managers voting on “To amend our Certificate of Incorporation to remove supermajority voting provisions.” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,999,803103 180For
Fidelity97,176,3560 00For
BlackRock47,761,3770 00For
State Street18,264,3400 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,564,9610 00For

Showing the 25 largest of 204 asset managers. All 204 are in the interactive database (link above).

The amendment of the Company's Third Restated Certificate of Incorporation and Amended and Restated By-Laws to permit…

Official resultCORPORATE GOVERNANCEReported outcome: Not approved

Combines 2 wordings of this item as funds reported it.

98% Not approved · of votes cast

FOR 98%
FOR: 1,095,371,430AGAINST: 20,945,183
Details: description as filed, official tally, votes by 204 asset managers

Description as filed by funds: To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders.

Boston Scientific Corporation’s own tally for this item (“7. The amendment of the Company's Third Restated Certificate of Incorporation and Amended and Restated By-Laws to permit stockholders owning not less than 25% of the Company's common stock to call a special meeting of st”): 1,095,371,430 for, 20,945,183 against — failed, per its Form 8-K filed May 5, 2026 (Item 5.07). This item required more than a simple majority of votes cast — see the filing.

Reported outcome: Not approved, in the filing’s own words: “(7) The stockholders did not approve the amendment of the Company's Third Restated Certificate of Incorporation and Amended and Restated By-Laws to permit stockholders owning not less than 25% of the Company's common stock to call a special meeting of stockholders.”
Not approved: the filing states that this item needed more than a majority of the votes cast.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 204 asset managers below reported 442,277,448 for, 328,263 against, 33,923,684 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 442,277,448AGAINST: 328,263ABSTAIN: 33,923,684UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock t” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard136,296,214203,763 29,499,9470Mixed
Fidelity97,176,3560 00For
BlackRock47,719,10625,911 16,3600For
State Street18,234,52629,814 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,686,4950 2,5220For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds00 1,606,6000Abstain
Neuberger Berman1,605,9850 00For
Equitable1,564,9610 00For

Showing the 25 largest of 204 asset managers. All 204 are in the interactive database (link above).

The amendment of the Company's Employee Stock Purchase Plan to increase the number of shares reserved for issuance

Official resultCAPITAL STRUCTUREReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%
FOR: 1,205,130,032AGAINST: 2,818,667
Details: description as filed, official tally, votes by 226 asset managers

Description as filed by funds: To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance.

Boston Scientific Corporation’s own tally for this item (“4. The amendment of the Company's Employee Stock Purchase Plan to increase the number of shares reserved for issuance”): 1,205,130,032 for, 2,818,667 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(4) The stockholders approved the amendment of the Company's Employee Stock Purchase Plan to increase the number of shares reserved for issuance.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 226 asset managers below reported 480,572,132 for, 151,281 against, 13 abstained, 1,125 not voted, 24,198 unknown.

FOR
FOR: 480,572,132AGAINST: 151,281ABSTAIN: 13UNKNOWN: 24,198NOT VOTED: 1,125
Largest asset managers voting on “To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance.” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,999,89815 130For
Fidelity97,176,3560 00For
BlackRock47,761,3770 00For
State Street18,264,3400 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
Navera Investment Management Ltd.1,615,5140 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For

Showing the 25 largest of 226 asset managers. All 226 are in the interactive database (link above).

The compensation of the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 29 wordings of this item as funds reported it.

91% Approved · of votes cast

FOR 91%
FOR: 1,096,889,576AGAINST: 110,645,813

Prior year: 91.9% for (May 1, 2025 meeting) ▼ 1.0 pts

Details: description as filed, official tally, votes by 1,257 asset managers

Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of our named executive officers.

Boston Scientific Corporation’s own tally for this item (“2. The compensation of the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the Annual Meeting”): 1,096,889,576 for, 110,645,813 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(2) The stockholders approved, on an advisory basis, the compensation of the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the Annual Meeting.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Boston Scientific Corporation’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Say on Pay” (3 managers, 98,123 for, 2,560 against).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 198 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,999,319589 150For
Fidelity97,176,3560 00For
BlackRock47,761,3770 00For
State Street18,264,131209 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,029,75815,000 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,542,41322,548 00For

Fund voting reports, all 198 managers: 476,203,300 for, 565,671 against, 142,670 abstained, 1,126 not voted, 24,011 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1,097 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity80,564,5800 00For
BlackRock67,411,0065,871 00For
State Street42,639,760463,415 00For
GEODE CAPITAL MANAGEMENT, LLC33,079,3910 00For
Janus Henderson32,546,05749,734 00For
PRIMECAP MANAGEMENT CO/CA/31,580,3640 00For
Invesco21,680,7260 00For
UBS16,478,764547,813 00For
Vanguard15,025,6300 00For
Capital Group14,948,9910 00For
Amundi013,822,851 00Against
Putnam13,790,9920 00For
Wellington12,766,1970 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/12,082,6710 00For
Union Investment Management GmbH011,973,403 00Against
DE Shaw11,514,4010 00For
Nuveen11,475,067694 00For
Goldman Sachs10,688,0620 00For
Northern Trust10,524,83382,943 00For
T. Rowe Price9,136,44235,438 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP8,562,041533,010 00Mixed
Charles Schwab8,900,8350 00For
Parnassus7,805,2490 00For
MELLON INVESTMENTS Corp7,215,4870 00For
Capital Research Global Investors7,063,9960 00For

Institutional-manager reports, all 1,097 managers: 735,767,804 for, 83,717,534 against, 1,151,156 abstained, 411,068 not voted, 187 unknown. Showing the 25 largest; every one is in the interactive database (link above).

The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

91% Approved · of votes cast

FOR 91%
FOR: 1,169,955,769AGAINST: 116,874,243

Prior year: 91.4% for (May 1, 2025 meeting) ▼ 0.5 pts

Details: description as filed, official tally, votes by 211 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year.

Boston Scientific Corporation’s own tally for this item (“3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal year”): 1,169,955,769 for, 116,874,243 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(3) The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal year.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 211 asset managers below reported 475,132,222 for, 2,595,580 against, 142,679 abstained, 1,125 not voted, 24,011 unknown.

FOR
FOR: 475,132,222AGAINST: 2,595,580ABSTAIN: 142,679UNKNOWN: 24,011NOT VOTED: 1,125
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 20” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard165,882,980116,922 240For
Fidelity97,056,397119,959 00For
BlackRock47,752,8488,529 00For
State Street18,264,131209 00For
Capital Group16,587,6370 00For
TIAA11,025,5110 00For
JANUS INVESTMENT FUND10,623,3700 00For
Putnam9,521,6410 00For
Invesco8,985,7110 00For
JPMorgan8,850,5640 00For
Charles Schwab8,689,0170 00For
Parnassus7,000,6460 00For
MFS5,192,4910 00For
ADVISORS' INNER CIRCLE FUND3,412,2170 00For
Dimensional3,064,6700 00For
T. Rowe Price3,044,7580 00For
Jackson National2,688,2800 00For
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND2,413,4360 00For
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO2,307,1260 00For
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds1,606,6000 00For
Neuberger Berman1,605,9850 00For
Equitable1,542,41322,548 00For

Showing the 25 largest of 211 asset managers. All 211 are in the interactive database (link above).

Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."

Official resultSHAREHOLDER RIGHTS AND DEFENSESReported outcome: Not approved

Combines 7 wordings of this item as funds reported it.

43% Not approved · of votes cast

FOR 43%AGAINST
FOR: 516,140,863AGAINST: 689,739,605
Details: official tally, votes by 208 asset managers

Boston Scientific Corporation’s own tally for this item (“8. The stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."”): 516,140,863 for, 689,739,605 against — failed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “(8) The stockholders did not approve the stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."”
Support: 43% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 208 asset managers below reported 79,985,967 for, 397,025,465 against, 142,680 abstained, 1,125 not voted, 25,007 unknown.

FORAGAINST
FOR: 79,985,967AGAINST: 397,025,465ABSTAIN: 142,680UNKNOWN: 25,007NOT VOTED: 1,125
Largest asset managers voting on “Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."” at Boston Scientific Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard11,626,825154,373,075 250Mixed
Fidelity1,264,98395,911,373 00Against
BlackRock79,11547,682,262 00Against
State Street35,88718,228,453 00Against
Capital Group16,587,6370 00For
TIAA011,025,511 00Against
JANUS INVESTMENT FUND7,545,4663,077,904 00Mixed
Putnam09,521,641 00Against
Invesco4,742,8504,242,861 00Mixed
JPMorgan08,850,564 00Against
Charles Schwab2,5228,686,495 00Against
Parnassus7,000,6460 00For
MFS05,192,491 00Against
ADVISORS' INNER CIRCLE FUND74,6183,337,599 00Against
Dimensional03,064,670 00Against
T. Rowe Price03,044,758 00Against
Jackson National1,485,6711,202,609 00Mixed
Columbia Threadneedle2,629,5100 00For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND02,413,436 00Against
NEW ECONOMY FUND2,393,7270 00For
MASTER INVESTMENT PORTFOLIO02,307,126 00Against
Eaton Vance1,680,6780 00For
PRIMECAP Odyssey Funds01,606,600 00Against
Neuberger Berman01,605,985 00Against
Equitable1,184,088380,873 00Mixed

Showing the 25 largest of 208 asset managers. All 208 are in the interactive database (link above).

Not shown here: this season’s fund filings also report 1 item from the meeting of May 1, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest Boston Scientific Corporation shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 1,486,355,179 shares outstanding at the time of that meeting.

Fund voting reports: top Boston Scientific Corporation shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 11.17%
2Fidelity 6.54%
3BlackRock 3.21%
4State Street 1.23%
5Capital Group 1.12%
6TIAA 0.74%
7JANUS INVESTMENT FUND 0.71%
8Putnam 0.64%
9Invesco 0.60%
10JPMorgan 0.60%
Institutional-manager reports: top Boston Scientific Corporation shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 5.42%
2BlackRock 4.54%
3State Street 2.90%
4GEODE CAPITAL MANAGEMENT, LLC 2.23%
5Janus Henderson 2.19%
6PRIMECAP MANAGEMENT CO/CA/ 2.12%
7Invesco 1.46%
8UBS 1.15%
9Vanguard 1.01%
10Capital Group 1.01%

Reported Boston Scientific Corporation holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Boston Scientific Corporation holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock131,822,037 8.87%Form 13F, quarter ended March 31, 2026
FMR (Fidelity)74,226,395 4.99%Form 13F, quarter ended March 31, 2026
State Street67,986,847 4.57%Form 13F, quarter ended March 31, 2026
JPMorgan Chase33,350,157 2.24%Form 13F, quarter ended March 31, 2026
D.E. Shaw24,432,352 1.64%Form 13F, quarter ended March 31, 2026
Morgan Stanley22,960,556 1.54%Form 13F, quarter ended March 31, 2026
Goldman Sachs19,366,624 1.30%Form 13F, quarter ended March 31, 2026
Wellington Management18,833,406 1.27%Form 13F, quarter ended March 31, 2026

Percentages above are of 1,486,355,179 shares outstanding, as reported by Boston Scientific Corporation on its Form 10-Q dated April 29, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Boston Scientific Corporation's shareholder meeting held April 30, 2026, in the 2025-2026 proxy season, 1,259 asset managers reported votes on at least one of its 17 ballot items in their SEC Form N-PX filings, covering 21,280 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of our named executive officers. — Boston Scientific Corporation's filing reports the proposal as approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Boston Scientific Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 5, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Boston Scientific Corporation’s 10-Q dated April 29, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Boston Scientific Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Boston Scientific (BSX) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/boston-scientific-corp/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.